San Carlos, California-based Glycomine Inc, a biotechnology company, has raised $33 million in Series B financing. Novo Holdings A/S led the round.
Source: Press Release
San Carlos, California-based Glycomine Inc, a biotechnology company, has raised $33 million in Series B financing. Novo Holdings A/S led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.